Nanotechnology for Minimally Invasive Cancer Detection and Resection View Homepage


Ontology type: schema:MonetaryGrant     


Grant Info

YEARS

2012-2017

FUNDING AMOUNT

707892 USD

ABSTRACT

NANOTECHNOLOGY FOR MINIMALLY INVASIVE CANCER DETECTION AND RESECTION Project Abstract Effective surgical resection of tumors is the most important predictor for cancer patient survival. Although surgery is curative in approximately 45% of cancer patients, up to 40% of patients have recurrent tumors due to undetectable differences between malignant and benign hyperplasic or normal tissue, leading to incomplete resection of cancerous tissue. In addition, patients that undergo surgery often suffer a decreased quality of life due to injury associated with the surgery. The primary goal of this Pathway to Independence Award in Cancer Nanotechnology Research (K99/R00) proposal is to integrate the unique capabilities of nanotechnology with innovative optical instrumentation to improve detection and resection of malignant tissue through minimally invasive surgery. This challenge will be addressed by combining expertise and research methodology in nanotechnology, instrumentation, and surgical oncology. This career development award has four specific aims: (1) develop biodegradable and nontoxic activatable fluorescence nanoparticle probes; (2) develop a miniaturized and flexible device for intraoperative fluorescence detection; (3) integrate the miniaturized, flexible optical device with endoscopy for minimally invasive detection of tumors; and (4) evaluate the spectral endoscope using spontaneous thoracic tumors in large animals (canines) during surgery to improve disease clearance and pathological staging. Accomplishing these specific aims will utilize targeted and activatable nanoparticles to increase specific localization of the probes in cancerous tissue. Detecting and resecting cancerous tissue via the fiber optic endoscopic imaging system will decrease the rate of tumor recurrence by more accurately detecting surgical margins and residual cancer and reduce surgery associated morbidity, such as decreasing patient pain, discomfort, and disability. My immediate career goal is to obtain a tenure-track faculty position that focuses on integrating nanotechnology with surgical oncology. Long-term, I would like to lead a research program at the interface of science, medicine, and engineering and expand the number and types of diseases that will be investigated. Ideally this research would be performed at an institution where I can be involved with academic and medical investigators from diverse fields. Training during the mentored phase of this award will focus on several key aspects to facilitate my development to achieve these goals as an independent investigator, including (1) providing the candidate with a strong foundation in optical nanoparticle engineering, (2) instrumentation for fiber optic based spectral and near-infrared imaging, and (3) methodological challenges to minimally invasive laparoscopic procedures in surgical oncology. Training will take place in the Emory-Georgia Tech Biomedical Engineering Department under the mentorship of Dr. Shuming Nie, Ph.D., an international expert in nanotechnology and director of the Emory-Georgia Tech Center for Cancer Nanotechnology Excellence, and at the University of Pennsylvania under the co-mentorship of Dr. Sunil Singhal, M.D., Director of the Thoracic Surgery Research Laboratory and Chief of Thoracic Surgery. The environment at these two institutions is ideal for this project because I will have full access to the most advanced instrumentation for nanoparticle design, synthesis, and characterization; I will benefit from instrumentation engineers with fabrication facilities to meet my needs; and a highly collaborative translational environment, which is paramount for successful development of this project that integrates nanotechnology with minimally invasive intraoperative instrumentation. In addition, the collaborative training will be supplemented by formal coursework at Emory and Georgia Tech in optics and instrumentation. More... »

URL

http://projectreporter.nih.gov/project_info_description.cfm?aid=9102380

Related SciGraph Publications

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/2202", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/2211", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/2209", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "type": "DefinedTerm"
      }
    ], 
    "amount": {
      "currency": "USD", 
      "type": "MonetaryAmount", 
      "value": "707892"
    }, 
    "description": "NANOTECHNOLOGY FOR MINIMALLY INVASIVE CANCER DETECTION AND RESECTION Project Abstract Effective surgical resection of tumors is the most important predictor for cancer patient survival. Although surgery is curative in approximately 45% of cancer patients, up to 40% of patients have recurrent tumors due to undetectable differences between malignant and benign hyperplasic or normal tissue, leading to incomplete resection of cancerous tissue. In addition, patients that undergo surgery often suffer a decreased quality of life due to injury associated with the surgery. The primary goal of this Pathway to Independence Award in Cancer Nanotechnology Research (K99/R00) proposal is to integrate the unique capabilities of nanotechnology with innovative optical instrumentation to improve detection and resection of malignant tissue through minimally invasive surgery. This challenge will be addressed by combining expertise and research methodology in nanotechnology, instrumentation, and surgical oncology. This career development award has four specific aims: (1) develop biodegradable and nontoxic activatable fluorescence nanoparticle probes; (2) develop a miniaturized and flexible device for intraoperative fluorescence detection; (3) integrate the miniaturized, flexible optical device with endoscopy for minimally invasive detection of tumors; and (4) evaluate the spectral endoscope using spontaneous thoracic tumors in large animals (canines) during surgery to improve disease clearance and pathological staging. Accomplishing these specific aims will utilize targeted and activatable nanoparticles to increase specific localization of the probes in cancerous tissue. Detecting and resecting cancerous tissue via the fiber optic endoscopic imaging system will decrease the rate of tumor recurrence by more accurately detecting surgical margins and residual cancer and reduce surgery associated morbidity, such as decreasing patient pain, discomfort, and disability. My immediate career goal is to obtain a tenure-track faculty position that focuses on integrating nanotechnology with surgical oncology. Long-term, I would like to lead a research program at the interface of science, medicine, and engineering and expand the number and types of diseases that will be investigated. Ideally this research would be performed at an institution where I can be involved with academic and medical investigators from diverse fields. Training during the mentored phase of this award will focus on several key aspects to facilitate my development to achieve these goals as an independent investigator, including (1) providing the candidate with a strong foundation in optical nanoparticle engineering, (2) instrumentation for fiber optic based spectral and near-infrared imaging, and (3) methodological challenges to minimally invasive laparoscopic procedures in surgical oncology. Training will take place in the Emory-Georgia Tech Biomedical Engineering Department under the mentorship of Dr. Shuming Nie, Ph.D., an international expert in nanotechnology and director of the Emory-Georgia Tech Center for Cancer Nanotechnology Excellence, and at the University of Pennsylvania under the co-mentorship of Dr. Sunil Singhal, M.D., Director of the Thoracic Surgery Research Laboratory and Chief of Thoracic Surgery. The environment at these two institutions is ideal for this project because I will have full access to the most advanced instrumentation for nanoparticle design, synthesis, and characterization; I will benefit from instrumentation engineers with fabrication facilities to meet my needs; and a highly collaborative translational environment, which is paramount for successful development of this project that integrates nanotechnology with minimally invasive intraoperative instrumentation. In addition, the collaborative training will be supplemented by formal coursework at Emory and Georgia Tech in optics and instrumentation.", 
    "endDate": "2017-03-31T00:00:00Z", 
    "funder": {
      "id": "https://www.grid.ac/institutes/grid.48336.3a", 
      "type": "Organization"
    }, 
    "id": "sg:grant.2441571", 
    "identifier": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "2441571"
        ]
      }, 
      {
        "name": "nih_id", 
        "type": "PropertyValue", 
        "value": [
          "R00CA153916"
        ]
      }
    ], 
    "inLanguage": [
      "en"
    ], 
    "keywords": [
      "undetectable differences", 
      "activatable nanoparticles", 
      "Emory-Georgia Tech Center", 
      "Pennsylvania", 
      "flexible optical devices", 
      "large animals", 
      "decreased quality", 
      "nanoparticle design", 
      "methodological challenges", 
      "surgery", 
      "surgical margins", 
      "disability", 
      "endoscopy", 
      "training", 
      "injury", 
      "advanced instrumentation", 
      "primary goal", 
      "rate", 
      "fabrication facilities", 
      "invasive detection", 
      "invasive laparoscopic procedures", 
      "patient survival", 
      "formal coursework", 
      "challenges", 
      "mentored phase", 
      "co-mentorship", 
      "international experts", 
      "director", 
      "synthesis", 
      "cancer nanotechnology research", 
      "research methodology", 
      "invasive surgery", 
      "need", 
      "Thoracic Surgery Research Laboratory", 
      "expertise", 
      "project", 
      "mentorship", 
      "spontaneous thoracic tumors", 
      "place", 
      "collaborative translational environment", 
      "Ph.D.", 
      "medicine", 
      "nontoxic activatable fluorescence nanoparticle probes", 
      "pathological staging", 
      "specific localization", 
      "engineering", 
      "science", 
      "thoracic surgery", 
      "immediate career goal", 
      "disease clearance", 
      "Dr. Sunil Singhal", 
      "environment", 
      "tumor", 
      "strong foundation", 
      "residual cancer", 
      "innovative optical instrumentation", 
      "cancer detection", 
      "Georgia Tech", 
      "Emory", 
      "medical investigators", 
      "probe", 
      "addition", 
      "pathway", 
      "institutions", 
      "optics", 
      "normal tissues", 
      "benign hyperplasic", 
      "recurrent tumor", 
      "M.D.", 
      "several key aspects", 
      "research", 
      "career development awards", 
      "development", 
      "optical nanoparticle engineering", 
      "specific aim", 
      "cancer", 
      "cancerous tissues", 
      "detection", 
      "tumor recurrence", 
      "candidates", 
      "patients", 
      "tenure-track faculty positions", 
      "disease", 
      "cancer patients", 
      "life", 
      "surgical oncology", 
      "invasive intraoperative instrumentation", 
      "fiber optic endoscopic imaging system", 
      "important predictor", 
      "instrumentation", 
      "flexible devices", 
      "unique capability", 
      "characterization", 
      "award", 
      "incomplete resection", 
      "RESECTION Project Abstract Effective surgical resection", 
      "patient's pain", 
      "successful development", 
      "Dr. Shuming Nie", 
      "discomfort", 
      "independent investigators", 
      "Cancer Nanotechnology Excellence", 
      "type", 
      "intraoperative fluorescence detection", 
      "goal", 
      "research program", 
      "diverse fields", 
      "canine", 
      "fiber optics", 
      "Emory-Georgia Tech Biomedical Engineering Department", 
      "near-infrared imaging", 
      "interface", 
      "resection", 
      "K99/R00", 
      "proposal", 
      "full access", 
      "nanotechnology", 
      "spectral endoscope", 
      "collaborative training", 
      "University", 
      "malignant tissues", 
      "Independence Award", 
      "Chief", 
      "instrumentation engineers", 
      "number", 
      "morbidity", 
      "invasive cancer detection"
    ], 
    "name": "Nanotechnology for Minimally Invasive Cancer Detection and Resection", 
    "recipient": [
      {
        "id": "https://www.grid.ac/institutes/grid.266813.8", 
        "type": "Organization"
      }, 
      {
        "affiliation": {
          "id": "https://www.grid.ac/institutes/grid.266813.8", 
          "name": "UNIVERSITY OF NEBRASKA MEDICAL CENTER", 
          "type": "Organization"
        }, 
        "familyName": "MOHS", 
        "givenName": "AARON M.", 
        "id": "sg:person.01300310235.53", 
        "type": "Person"
      }, 
      {
        "member": "sg:person.01300310235.53", 
        "roleName": "PI", 
        "type": "Role"
      }
    ], 
    "sameAs": [
      "https://app.dimensions.ai/details/grant/grant.2441571"
    ], 
    "sdDataset": "grants", 
    "sdDatePublished": "2019-03-07T12:12", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com.uberresearch.data.processor/core_data/20181219_192338/projects/base/nih_projects_5.xml.gz", 
    "startDate": "2012-04-01T00:00:00Z", 
    "type": "MonetaryGrant", 
    "url": "http://projectreporter.nih.gov/project_info_description.cfm?aid=9102380"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/grant.2441571'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/grant.2441571'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/grant.2441571'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/grant.2441571'


 

This table displays all metadata directly associated to this object as RDF triples.

177 TRIPLES      19 PREDICATES      151 URIs      141 LITERALS      5 BLANK NODES

Subject Predicate Object
1 sg:grant.2441571 schema:about anzsrc-for:2202
2 anzsrc-for:2209
3 anzsrc-for:2211
4 schema:amount Nd4be16efa8db458fbfaae806bfcd4cd4
5 schema:description NANOTECHNOLOGY FOR MINIMALLY INVASIVE CANCER DETECTION AND RESECTION Project Abstract Effective surgical resection of tumors is the most important predictor for cancer patient survival. Although surgery is curative in approximately 45% of cancer patients, up to 40% of patients have recurrent tumors due to undetectable differences between malignant and benign hyperplasic or normal tissue, leading to incomplete resection of cancerous tissue. In addition, patients that undergo surgery often suffer a decreased quality of life due to injury associated with the surgery. The primary goal of this Pathway to Independence Award in Cancer Nanotechnology Research (K99/R00) proposal is to integrate the unique capabilities of nanotechnology with innovative optical instrumentation to improve detection and resection of malignant tissue through minimally invasive surgery. This challenge will be addressed by combining expertise and research methodology in nanotechnology, instrumentation, and surgical oncology. This career development award has four specific aims: (1) develop biodegradable and nontoxic activatable fluorescence nanoparticle probes; (2) develop a miniaturized and flexible device for intraoperative fluorescence detection; (3) integrate the miniaturized, flexible optical device with endoscopy for minimally invasive detection of tumors; and (4) evaluate the spectral endoscope using spontaneous thoracic tumors in large animals (canines) during surgery to improve disease clearance and pathological staging. Accomplishing these specific aims will utilize targeted and activatable nanoparticles to increase specific localization of the probes in cancerous tissue. Detecting and resecting cancerous tissue via the fiber optic endoscopic imaging system will decrease the rate of tumor recurrence by more accurately detecting surgical margins and residual cancer and reduce surgery associated morbidity, such as decreasing patient pain, discomfort, and disability. My immediate career goal is to obtain a tenure-track faculty position that focuses on integrating nanotechnology with surgical oncology. Long-term, I would like to lead a research program at the interface of science, medicine, and engineering and expand the number and types of diseases that will be investigated. Ideally this research would be performed at an institution where I can be involved with academic and medical investigators from diverse fields. Training during the mentored phase of this award will focus on several key aspects to facilitate my development to achieve these goals as an independent investigator, including (1) providing the candidate with a strong foundation in optical nanoparticle engineering, (2) instrumentation for fiber optic based spectral and near-infrared imaging, and (3) methodological challenges to minimally invasive laparoscopic procedures in surgical oncology. Training will take place in the Emory-Georgia Tech Biomedical Engineering Department under the mentorship of Dr. Shuming Nie, Ph.D., an international expert in nanotechnology and director of the Emory-Georgia Tech Center for Cancer Nanotechnology Excellence, and at the University of Pennsylvania under the co-mentorship of Dr. Sunil Singhal, M.D., Director of the Thoracic Surgery Research Laboratory and Chief of Thoracic Surgery. The environment at these two institutions is ideal for this project because I will have full access to the most advanced instrumentation for nanoparticle design, synthesis, and characterization; I will benefit from instrumentation engineers with fabrication facilities to meet my needs; and a highly collaborative translational environment, which is paramount for successful development of this project that integrates nanotechnology with minimally invasive intraoperative instrumentation. In addition, the collaborative training will be supplemented by formal coursework at Emory and Georgia Tech in optics and instrumentation.
6 schema:endDate 2017-03-31T00:00:00Z
7 schema:funder https://www.grid.ac/institutes/grid.48336.3a
8 schema:identifier N26963243d76f4ac5b8f2190ebfd90e20
9 Ne230ebc104714e2881f7c614ed846cfd
10 schema:inLanguage en
11 schema:keywords Cancer Nanotechnology Excellence
12 Chief
13 Dr. Shuming Nie
14 Dr. Sunil Singhal
15 Emory
16 Emory-Georgia Tech Biomedical Engineering Department
17 Emory-Georgia Tech Center
18 Georgia Tech
19 Independence Award
20 K99/R00
21 M.D.
22 Pennsylvania
23 Ph.D.
24 RESECTION Project Abstract Effective surgical resection
25 Thoracic Surgery Research Laboratory
26 University
27 activatable nanoparticles
28 addition
29 advanced instrumentation
30 award
31 benign hyperplasic
32 cancer
33 cancer detection
34 cancer nanotechnology research
35 cancer patients
36 cancerous tissues
37 candidates
38 canine
39 career development awards
40 challenges
41 characterization
42 co-mentorship
43 collaborative training
44 collaborative translational environment
45 decreased quality
46 detection
47 development
48 director
49 disability
50 discomfort
51 disease
52 disease clearance
53 diverse fields
54 endoscopy
55 engineering
56 environment
57 expertise
58 fabrication facilities
59 fiber optic endoscopic imaging system
60 fiber optics
61 flexible devices
62 flexible optical devices
63 formal coursework
64 full access
65 goal
66 immediate career goal
67 important predictor
68 incomplete resection
69 independent investigators
70 injury
71 innovative optical instrumentation
72 institutions
73 instrumentation
74 instrumentation engineers
75 interface
76 international experts
77 intraoperative fluorescence detection
78 invasive cancer detection
79 invasive detection
80 invasive intraoperative instrumentation
81 invasive laparoscopic procedures
82 invasive surgery
83 large animals
84 life
85 malignant tissues
86 medical investigators
87 medicine
88 mentored phase
89 mentorship
90 methodological challenges
91 morbidity
92 nanoparticle design
93 nanotechnology
94 near-infrared imaging
95 need
96 nontoxic activatable fluorescence nanoparticle probes
97 normal tissues
98 number
99 optical nanoparticle engineering
100 optics
101 pathological staging
102 pathway
103 patient survival
104 patient's pain
105 patients
106 place
107 primary goal
108 probe
109 project
110 proposal
111 rate
112 recurrent tumor
113 research
114 research methodology
115 research program
116 resection
117 residual cancer
118 science
119 several key aspects
120 specific aim
121 specific localization
122 spectral endoscope
123 spontaneous thoracic tumors
124 strong foundation
125 successful development
126 surgery
127 surgical margins
128 surgical oncology
129 synthesis
130 tenure-track faculty positions
131 thoracic surgery
132 training
133 tumor
134 tumor recurrence
135 type
136 undetectable differences
137 unique capability
138 schema:name Nanotechnology for Minimally Invasive Cancer Detection and Resection
139 schema:recipient N46357fa888704ff68edf498e916351ed
140 sg:person.01300310235.53
141 https://www.grid.ac/institutes/grid.266813.8
142 schema:sameAs https://app.dimensions.ai/details/grant/grant.2441571
143 schema:sdDatePublished 2019-03-07T12:12
144 schema:sdLicense https://scigraph.springernature.com/explorer/license/
145 schema:sdPublisher N4eb0b7a639624a45b0817590979bd813
146 schema:startDate 2012-04-01T00:00:00Z
147 schema:url http://projectreporter.nih.gov/project_info_description.cfm?aid=9102380
148 sgo:license sg:explorer/license/
149 sgo:sdDataset grants
150 rdf:type schema:MonetaryGrant
151 N26963243d76f4ac5b8f2190ebfd90e20 schema:name nih_id
152 schema:value R00CA153916
153 rdf:type schema:PropertyValue
154 N46357fa888704ff68edf498e916351ed schema:member sg:person.01300310235.53
155 schema:roleName PI
156 rdf:type schema:Role
157 N4eb0b7a639624a45b0817590979bd813 schema:name Springer Nature - SN SciGraph project
158 rdf:type schema:Organization
159 Nd4be16efa8db458fbfaae806bfcd4cd4 schema:currency USD
160 schema:value 707892
161 rdf:type schema:MonetaryAmount
162 Ne230ebc104714e2881f7c614ed846cfd schema:name dimensions_id
163 schema:value 2441571
164 rdf:type schema:PropertyValue
165 anzsrc-for:2202 schema:inDefinedTermSet anzsrc-for:
166 rdf:type schema:DefinedTerm
167 anzsrc-for:2209 schema:inDefinedTermSet anzsrc-for:
168 rdf:type schema:DefinedTerm
169 anzsrc-for:2211 schema:inDefinedTermSet anzsrc-for:
170 rdf:type schema:DefinedTerm
171 sg:person.01300310235.53 schema:affiliation https://www.grid.ac/institutes/grid.266813.8
172 schema:familyName MOHS
173 schema:givenName AARON M.
174 rdf:type schema:Person
175 https://www.grid.ac/institutes/grid.266813.8 schema:name UNIVERSITY OF NEBRASKA MEDICAL CENTER
176 rdf:type schema:Organization
177 https://www.grid.ac/institutes/grid.48336.3a schema:Organization
 




Preview window. Press ESC to close (or click here)


...